Maravai LifeSciences Raises FY2026 Sales Guidance from $205.000M-$215.000M to $212.000M-$216.000M vs $211.767M Est
Benzinga Newsdesk 3 hours ago
NewsGuidance
Maravai LifeSciences (NASDAQ:MRVI) raises FY2026 sales outlook from $205.000 million-$215.000 million to $212.000 million-$216.000 million vs $211.767 million estimate.
Maravai LifeSciences (NASDAQ:MRVI) raises FY2026 sales outlook from $205.000 million-$215.000 million to $212.000 million-$216.000 million vs $211.767 million estimate.